ATS

DALLAS--Results of 3 studies presented at the American Thoracic Society meeting this week focus on the predictive role of disease exacerbations, machine learning, and Hgb levels in COPD. 

DALLAS-At the American Thoracic Society meeting thought leaders cited disturbing trends in e-cigarette use by teens and warned of health dangers, known and unknown.

DALLAS--Supplemental oxygen helps patients with lung disease manage better day-to-day, but according to speakers gathered at the ATS meeting in Dallas this week, it can also add to disease burden.

DALLAS--Which patients are candidates for antifibrotic therapy? Is extracorporeal membrane oxygenation appropriate for all ILD patients? The topics were hotly debated on Monday at the American Thoracic Society meeting. 

Dorothy is 55-years-old, has never smoked, and was well until 1 year ago when she first noticed mild dyspnea on exertion; it has gotten progressively worse.

A pulmonologist answers some of the most common questions he hears from colleagues and students about COPD exacerbations and their management.

A pulmonologist describes an approach to guide the primary care clinician faced with a patient in whom interstitial lung disease is suspected.